Live from the NIH registry
Studies recruiting near Baltimore right now
Top 25 of 1,646 recruiting studies, sorted by proximity — each links to its official registry page
Nephrotic Syndrome Study Network
Minimal Change Disease (MCD), Membranous Nephropathy
N/A
Observational 1,200 participants sought
Johns Hopkins Medical Institute — Baltimore, Maryland (1.0 mi)
· Sponsor: University of Michigan
Human Craniomaxillofacial Allotransplantation
Facial Injuries, Traumatic Wounds and Injuries
Phase 2
Interventional 15 participants sought
Johns Hopkins University School of Medicine — Baltimore, Maryland (1.0 mi)
· Sponsor: Johns Hopkins University
Regional or Extend LymphAdenectomy During Resection of Intrahepatic Cholangiocarcinoma
Intrahepatic Cholangiocarcinoma
N/A
Interventional 168 participants sought
The Johns Hopkins Hospital — Baltimore, Maryland (1.0 mi)
· Sponsor: Second Affiliated Hospital, Zhejiang University, School of Medicine
Skeletal Muscle Energetics and Fatiguability in Older Individuals
HIV, HIV Infections
N/A
Observational 200 participants sought
Johns Hopkins Hospital — Baltimore, Maryland (1.0 mi)
· Sponsor: Johns Hopkins University
Bipolar Androgen Therapy (BAT) and Radium-223 (RAD) in Metastatic Castration-resistant Prostate Cancer (mCRPC)
Prostate Adenocarcinoma, Metastatic Prostate Adenocarcinoma
Phase 2
Interventional 47 participants sought
Amber Michalik — Baltimore, Maryland (1.0 mi)
· Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins
Study of RMC-9805 in Participants With KRAS G12D-Mutant Solid Tumors
Non-small Cell Lung Cancer (NSCLC), Colorectal Cancer (CRC)
Phase 1
Interventional 604 participants sought
Johns Hopkins University — Baltimore, Maryland (1.0 mi)
· Sponsor: Revolution Medicines, Inc.
A Study Testing the Combination of Dasatinib or Imatinib to Chemotherapy Treatment With Blinatumomab for Children, Adolescents, and Young Adults With Philadelphia Chromosome Positive (Ph+) or ABL-Class Philadelphia Chromosome-Like (Ph-Like) B-cell Acute Lymphoblastic Leukemia (B-ALL)
B Acute Lymphoblastic Leukemia
Phase 2
Interventional 222 participants sought
Sinai Hospital of Baltimore — Baltimore, Maryland (1.0 mi)
· Sponsor: National Cancer Institute (NCI)
Vaporized Cannabis Administration and Co-Administration of Alcohol on Impairment
Cannabis Intoxication, Alcohol Intoxication
Phase 1
Interventional 90 participants sought
Johns Hopkins Behavioral Pharmacology Research Unit — Baltimore, Maryland (1.0 mi)
· Sponsor: Johns Hopkins University
Study to Assess the Impact of the Urine Test Cxbladder Triage Plus on the Number of Cystoscopies Performed on Patients With Invisible Blood in Their Urine.
Hematuria - Cause Not Known
N/A
Interventional 1,000 participants sought
Chesapeake Urology Research Associates — Hanover, Maryland (9.7 mi)
· Sponsor: Pacific Edge Limited
A Phase II Nationwide, Fully Decentralized, Telemedicine Study of Pemigatinib in Adult Patients With Advanced or Metastatic Pancreatic Cancer With FGFR Genetic Alterations
Advanced Pancreatic Carcinoma, Metastatic Pancreatic Carcinoma
Phase 2
Interventional 40 participants sought
Ohio State University-Telemedicine — Baltimore, Maryland (1.0 mi)
· Sponsor: Sameek Roychowdhury
WISPer: Evaluation of MTX-463 in Participants With Idiopathic Pulmonary Fibrosis (IPF)
Idiopathic Pulmonary Fibrosis
Phase 2
Interventional 164 participants sought
WISPer Site in Baltimore, MD — Baltimore, Maryland (1.0 mi)
· Sponsor: Mediar Therapeutics
A Study of Brenipatide in Participants With Alcohol Use Disorder
Alcohol Use Disorder
Phase 3
Interventional 1,100 participants sought
Maryland Treatment Centers - Mountain Manor Treatment Center — Baltimore, Maryland (1.0 mi)
· Sponsor: Eli Lilly and Company
GATEWAY: Safety Evaluation of the MiniMed™ NMX8-AID System in Children and Adults Living With Diabetes
Type 1 Diabetes Mellitus, Type 2 Diabetes Mellitus
N/A
Interventional 400 participants sought
Barry J. Reiner, MD LLC — Baltimore, Maryland (1.0 mi)
· Sponsor: Medtronic MiniMed, Inc.
Adaptive Mobile Interventions to Reduce Cancer Risk Behaviors
Smoking Cessation
N/A
Interventional 7 participants sought
Johns Hopkins Bloomberg School of Public Health — Baltimore, Maryland (1.0 mi)
· Sponsor: Johns Hopkins Bloomberg School of Public Health
Lung-MAP: A Master Screening Protocol for Previously-Treated Non-Small Cell Lung Cancer
Previously Treated Non-Small Cell Lung Cancer
Phase 2, Phase 3
Interventional 10,000 participants sought
University of Maryland/Greenebaum Cancer Center — Baltimore, Maryland (1.0 mi)
· Sponsor: SWOG Cancer Research Network
Diagnostic Strategies, Risk Assessment and Progression of Pancreatic Cysts
Pancreatic Neoplasms, Pancreas Cancer
N/A
Observational 5,000 participants sought
The Johns Hopkins Hospital — Baltimore, Maryland (1.0 mi)
· Sponsor: Johns Hopkins University
Extracorporeal Photopheresis in Sezary Syndrome
Sezary Syndrome
N/A
Observational 20 participants sought
Cutaneous Translational Research Program - Johns Hopkins Medicine — Baltimore, Maryland (1.0 mi)
· Sponsor: Oleg E. Akilov, MD, PhD
Development and Validation of Learning and Decision-Making Tasks
Normal Physiology
N/A
Observational 550 participants sought
National Institute on Drug Abuse — Baltimore, Maryland (1.0 mi)
· Sponsor: National Institute on Drug Abuse (NIDA)
A Study of the Efficacy and Safety of Belimumab in Adults With Systemic Sclerosis Associated Interstitial Lung Disease
Systemic Sclerosis Associated Interstitial Lung Disease, Scleroderma, Systemic
Phase 2, Phase 3
Interventional 300 participants sought
GSK Investigational Site — Baltimore, Maryland (1.0 mi)
· Sponsor: GlaxoSmithKline
Mirdametinib Monotherapy in Adults With Neurofibromatosis 1 (NF1) and Cutaneous Neurofibromas (cNF).
NF1, Cutaneous Neurofibroma
Phase 1, Phase 2
Interventional 24 participants sought
Johns Hopkins Hospital — Baltimore, Maryland (1.0 mi)
· Sponsor: Johns Hopkins University
Consolidation of First-Line MRD+ Remission With Cema-cel in Patients With LBCL
Large B-cell Lymphoma
Phase 2
Interventional 250 participants sought
University of Maryland Greenebaum Comprehensive Cancer Center — Baltimore, Maryland (1.0 mi)
· Sponsor: Allogene Therapeutics
Doxycycline Prophylaxis for Prevention of Sexually Transmitted Infections
Gonorrhea, Chlamydia
Phase 4
Interventional 760 participants sought
Johns Hopkins University — Baltimore, Maryland (1.0 mi)
· Sponsor: Westat
RENAISSANCE 2: SPN-817 Phase 2, Double-Blind, Placebo-Controlled Study in Adults With Focal Onset Seizures
Focal Onset Seizures
Phase 2
Interventional 216 participants sought
Johns Hopkins University — Baltimore, Maryland (1.0 mi)
· Sponsor: Supernus Pharmaceuticals, Inc.
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
Endometrial Cancer
Phase 3
Interventional 600 participants sought
Research Site — Baltimore, Maryland (1.0 mi)
· Sponsor: AstraZeneca
Momelotinib in Combination With Hypomethylating Agent for Chronic Phase Myelodysplastic Syndromes/Myeloproliferative Overlap Neoplasms and Chronic Neutrophilic Leukemia
Chronic Myelomonocytic Leukemia, Myelodysplastic Syndromes
EARLY/Phase 1
Interventional 18 participants sought
Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins — Baltimore, Maryland (1.0 mi)
· Sponsor: Sidney Kimmel Comprehensive Cancer Center at Johns Hopkins